phenol has been researched along with Malignant Melanoma in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The limitations of using polyphenols are also pointed out, which are related to their poor bioavailability and stability, but as the technology is well developed, it is possible to augment the efficacy of polyphenols in the case of melanoma." | 2.72 | Recent Advances in Phenolic Metabolites and Skin Cancer. ( Diaconeasa, Z; Pop, TD, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pop, TD | 1 |
| Diaconeasa, Z | 1 |
| Rolfs, F | 1 |
| Piersma, SR | 1 |
| Dias, MP | 1 |
| Jonkers, J | 1 |
| Jimenez, CR | 1 |
| Yamazaki, Y | 1 |
| Kawano, Y | 1 |
| Yamanaka, A | 1 |
| Maruyama, S | 1 |
| KERTESZ, D | 1 |
| Gong, YQ | 1 |
| Fan, Y | 1 |
| Wu, DZ | 1 |
| Yang, H | 1 |
| Hu, ZB | 1 |
| Wang, ZT | 1 |
| Jimbow, K | 1 |
| Iwashina, T | 1 |
| Alena, F | 1 |
| Yamada, K | 1 |
| Pankovich, J | 1 |
| Umemura, T | 1 |
1 review available for phenol and Malignant Melanoma
| Article | Year |
|---|---|
Recent Advances in Phenolic Metabolites and Skin Cancer.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antioxidants; Apoptosis; Autophagy; Cell | 2021 |
5 other studies available for phenol and Malignant Melanoma
| Article | Year |
|---|---|
Feasibility of Phosphoproteomics on Leftover Samples After RNA Extraction With Guanidinium Thiocyanate.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Chloroform; DNA Damage; Feasibility Studies; Guanidin | 2021 |
N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Enz | 2009 |
The phenol-oxidizing enzyme system of human melanomas; substrate specificity and relationship to copper.
Topics: Copper; Humans; Melanoma; Oxidoreductases; Phenol; Phenols; Substrate Specificity | 1954 |
In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent.
Topics: 3T3 Cells; Angiogenesis Inhibitors; Animals; Bibenzyls; Carcinoma, Hepatocellular; Drug Evaluation, | 2004 |
Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma.
Topics: Benzoquinones; Catechols; Cysteinyldopa; Dihydroxyphenylalanine; Dopamine; Humans; Indoles; Melanins | 1993 |